Biologic shown to reduce eczema symptoms in young children by three quarters

A biologic drug has been shown to reduce eczema symptoms in infants and young children by 75% in what is thought to be the first study of a monoclonal antibody for the treatment of skin conditions in children. The study, led by Northwestern Medicine in Chicago, found that a monoclonal antibody, known as dupilumab, is […]